The MCB Group has reported a strong financial performance for the nine-month period ending on 31 March 2023, with group profits attributable to ordinary shareholders increasing...
The SBM Group has delivered strong financial results, with profit attributable to equity holders of the parent more than doubling to attain Rs3.6 billion for the...
The Ministry of Commerce and Consumer Protection will soon apply a regressive mark-up mechanism on eight out of eleven classes of pharmaceutical products. These are Biologicals,...
